Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study.

Semenova T, Nemoz B, Thibault V, Lagathu G, Duverlie G, Brochot E, Trimoulet P, Payan C, Vallet S, Henquell C, Chevaliez S, Bouvier-Alias M, Maylin S, Roque-Afonso AM, Izquierdo L, Lunel-Fabiani F, Marcellin P, Morand P, Leroy V, Larrat S.

Epidemiol Infect. 2019 Jan;147:e234. doi: 10.1017/S0950268819001225.

2.

Genetic diversity of genotype 6 HCV infections in France: Epidemiology and consequences for treatment strategy.

Pronier C, Fontaine H, Dorival C, Carrat F, Pol S, Thibault V; AFEF/ANRS Hepather study group.

J Viral Hepat. 2019 Nov;26(11):1276-1283. doi: 10.1111/jvh.13171. Epub 2019 Jul 29.

PMID:
31273896
3.

Control of paratuberculosis: who, why and how. A review of 48 countries.

Whittington R, Donat K, Weber MF, Kelton D, Nielsen SS, Eisenberg S, Arrigoni N, Juste R, Sáez JL, Dhand N, Santi A, Michel A, Barkema H, Kralik P, Kostoulas P, Citer L, Griffin F, Barwell R, Moreira MAS, Slana I, Koehler H, Singh SV, Yoo HS, Chávez-Gris G, Goodridge A, Ocepek M, Garrido J, Stevenson K, Collins M, Alonso B, Cirone K, Paolicchi F, Gavey L, Rahman MT, de Marchin E, Van Praet W, Bauman C, Fecteau G, McKenna S, Salgado M, Fernández-Silva J, Dziedzinska R, Echeverría G, Seppänen J, Thibault V, Fridriksdottir V, Derakhshandeh A, Haghkhah M, Ruocco L, Kawaji S, Momotani E, Heuer C, Norton S, Cadmus S, Agdestein A, Kampen A, Szteyn J, Frössling J, Schwan E, Caldow G, Strain S, Carter M, Wells S, Munyeme M, Wolf R, Gurung R, Verdugo C, Fourichon C, Yamamoto T, Thapaliya S, Di Labio E, Ekgatat M, Gil A, Alesandre AN, Piaggio J, Suanes A, de Waard JH.

BMC Vet Res. 2019 Jun 13;15(1):198. doi: 10.1186/s12917-019-1943-4. Review.

4.

High clustering of acute HCV infections and high rate of associated STIs among Parisian HIV-positive male patients.

Todesco E, Day N, Amiel C, Elaerts S, Schneider V, Roudière L, Hué S, Liotier JY, Bottero J, L'Yavanc T, Ohayon M, Gosset D, Thibault V, Surgers L, Chas J, Akhavan S, Velter A, Katlama C, Kreplak G, Marcelin AG, Valantin MA.

Int J Antimicrob Agents. 2019 May;53(5):678-681. doi: 10.1016/j.ijantimicag.2019.02.002. Epub 2019 Feb 8.

5.

LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis.

Poynard T, Peta V, Deckmyn O, Munteanu M, Moussalli J, Ngo Y, Rudler M, Lebray P, Pais R, Bonyhay L, Charlotte F, Thibault V, Fartoux L, Lucidarme O, Eyraud D, Scatton O, Savier E, Valantin MA, Ngo A, Drane F, Rosmorduc O, Imbert-Bismut F, Housset C, Thabut D, Ratziu V; HECAM-FibroFrance Group.

Aliment Pharmacol Ther. 2019 Feb;49(3):308-320. doi: 10.1111/apt.15082. Epub 2018 Dec 19.

6.

Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease.

Munteanu M, Pais R, Peta V, Deckmyn O, Moussalli J, Ngo Y, Rudler M, Lebray P, Charlotte F, Thibault V, Lucidarme O, Ngo A, Imbert-Bismut F, Housset C, Thabut D, Ratziu V, Poynard T; FibroFrance Group.

Aliment Pharmacol Ther. 2018 Nov;48(10):1117-1127. doi: 10.1111/apt.14990. Epub 2018 Oct 17.

7.

Performance comparison of new Veris and Xpert random access HIV-1 RNA quantification assays.

Pronier C, Boukthir S, Courtellemont L, Lagathu G, Maillard A, Thibault V.

Virol J. 2018 Oct 11;15(1):156. doi: 10.1186/s12985-018-1072-x.

8.

Contribution of quantitative viral markers to document hepatitis B virus compartmentalization in cerebrospinal fluid during hepatitis B with neuropathies.

Pronier C, Guyader D, Jézequel C, Tattevin P, Thibault V.

J Neurovirol. 2018 Dec;24(6):769-772. doi: 10.1007/s13365-018-0662-0. Epub 2018 Aug 10.

9.

Septal chondromucosal grafts in paralytic lagophthalmos.

Alban R, Anne Sophie F, Thibault V, Clément D, Sophie B, Pascal R.

J Plast Reconstr Aesthet Surg. 2018 Sep;71(9):1352-1361. doi: 10.1016/j.bjps.2018.04.021. Epub 2018 Jun 5.

PMID:
30007536
10.

Serum CXCL10, CXCL11, CXCL12, and CXCL14 chemokine patterns in patients with acute liver injury.

Chalin A, Lefevre B, Devisme C, Pronier C, Carrière V, Thibault V, Amiot L, Samson M.

Cytokine. 2018 Nov;111:500-504. doi: 10.1016/j.cyto.2018.05.029. Epub 2018 Jun 4.

11.

Hepatitis B virus reactivation after direct-acting antivirals for chronic hepatitis C infection.

Thibault V.

Lancet Gastroenterol Hepatol. 2018 Mar;3(3):145-147. doi: 10.1016/S2468-1253(18)30004-9. Epub 2018 Jan 19. No abstract available.

PMID:
29371018
12.

Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery.

Peta V, Tse C, Perazzo H, Munteanu M, Ngo Y, Ngo A, Ramanujam N, Verglas L, Mallet M, Ratziu V, Thabut D, Rudler M, Thibault V, Schuppe-Koistinen I, Bonnefont-Rousselot D, Hainque B, Imbert-Bismut F, Merz M, Kullak-Ublick G, Andrade R, van Boemmel F, Schott E, Poynard T; Drug Induced Liver Injury- Groupe Hospitalier Pitié-Salpêtrière; Drug Induced Liver Group of the Injury Safer and Faster Evidence-based Translation consortium.

PLoS One. 2017 Dec 29;12(12):e0189436. doi: 10.1371/journal.pone.0189436. eCollection 2017.

13.

Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study.

Roulot D, Thibault V, Laforest C, Fontaine H, Bronowicki JP, Asselah T, Bourlière M, Canva V, Leroy V, Loustaud-Ratti V, Ouzan D, Zoulim F, Schischmanoff O, Rousseau C, Renault A, Petrov-Sanchez V, Diallo A, Bellissant E, Serfaty L; ANRS HC32 QUATTRO study group.

Eur J Gastroenterol Hepatol. 2018 Mar;30(3):302-309. doi: 10.1097/MEG.0000000000001035.

PMID:
29271782
14.

Kallikrein-Related Peptidase 5 Contributes to H3N2 Influenza Virus Infection in Human Lungs.

Magnen M, Gueugnon F, Guillon A, Baranek T, Thibault VC, Petit-Courty A, de Veer SJ, Harris J, Humbles AA, Si-Tahar M, Courty Y.

J Virol. 2017 Jul 27;91(16). pii: e00421-17. doi: 10.1128/JVI.00421-17. Print 2017 Aug 15.

15.

[Chemotherapy for colorectal cancer: Pragmatic assessment of prescription changes and relative dose intensity].

Thibault V, Leguelinel-Blache G, Obled S, Loriot V, Phouttasang V, Wolf P, Bastide S, Cousin C, Favier M.

Bull Cancer. 2017 Sep;104(9):714-720. doi: 10.1016/j.bulcan.2017.04.006. Epub 2017 Jun 1. French.

PMID:
28578823
16.

Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin.

Todesco E, Demeret S, Calin R, Roque-Afonso AM, Thibault V, Mallet V, Akhavan S, Jaspard M, Peytavin G, Poynard T, Katlama C, Pourcher V.

AIDS. 2017 Jun 1;31(9):1346-1348. doi: 10.1097/QAD.0000000000001474. No abstract available.

PMID:
28492398
17.

Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma.

Le Guillou-Guillemette H, Pivert A, Bouthry E, Henquell C, Petsaris O, Ducancelle A, Veillon P, Vallet S, Alain S, Thibault V, Abravanel F, Rosenberg AA, André-Garnier E, Bour JB, Baazia Y, Trimoulet P, André P, Gaudy-Graffin C, Bettinger D, Larrat S, Signori-Schmuck A, Saoudin H, Pozzetto B, Lagathu G, Minjolle-Cha S, Stoll-Keller F, Pawlotsky JM, Izopet J, Payan C, Lunel-Fabiani F, Lemaire C.

PLoS One. 2017 Apr 10;12(4):e0174651. doi: 10.1371/journal.pone.0174651. eCollection 2017.

18.

Performance of HBsAg quantification assays for detection of Hepatitis B virus genotypes and diagnostic escape-variants in clinical samples.

Thibault V, Servant-Delmas A, Ly TD, Roque-Afonso AM, Laperche S.

J Clin Virol. 2017 Apr;89:14-21. doi: 10.1016/j.jcv.2017.02.001. Epub 2017 Feb 4.

PMID:
28189936
19.

Influence of a Pay-for-Performance Program on Glycemic Control in Patients Living with Diabetes by Family Physicians in a Canadian Province.

LeBlanc E, Bélanger M, Thibault V, Babin L, Greene B, Halpine S, Mancuso M.

Can J Diabetes. 2017 Apr;41(2):190-196. doi: 10.1016/j.jcjd.2016.09.008. Epub 2016 Nov 29.

PMID:
27908559
20.

Factors that could explain the increasing prevalence of type 2 diabetes among adults in a Canadian province: a critical review and analysis.

Thibault V, Bélanger M, LeBlanc E, Babin L, Halpine S, Greene B, Mancuso M.

Diabetol Metab Syndr. 2016 Nov 9;8:71. eCollection 2016. Review.

21.

Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity.

Ducancelle A, Pivert A, Bertrais S, Boursier J, Balan V, Veillon P, le Guillou-Guillemette H, Thibault V, Castelain S, Roquebert B, Coste-Burel M, Mackiewicz V, Schvoerer E, Larrat S, Maylin S, Alain S, Loustaud-Ratti V, Gordien E, Gozlan J, Brodard V, Chevaliez S, Calès P, Lunel-Fabiani F.

J Gastroenterol Hepatol. 2016 Oct;31(10):1750-1756. doi: 10.1111/jgh.13338.

PMID:
26992056
22.

Too Often Forgotten: Passive Transfer of Antibodies.

Thibault V, Pinte L, Vergez J, Leger JM, Liou A.

Clin Infect Dis. 2016 Sep 1;63(5):709-10. doi: 10.1093/cid/ciw337. Epub 2016 May 20. No abstract available.

PMID:
27208043
23.

[Beware of immunoglobulin's passive transfer when interpreting serological analyses!].

Pinte L, Vergez J, Liou A, Leger JM, Thibault V.

Presse Med. 2016 Jul-Aug;45(7-8 Pt 1):676-81. doi: 10.1016/j.lpm.2016.03.009. Epub 2016 Apr 28. French.

PMID:
27132942
24.

Altered expression of the CCN genes in the lungs of mice in response to cigarette smoke exposure and viral and bacterial infections.

Gueugnon F, Thibault VC, Kearley J, Petit-Courty A, Vallet A, Guillon A, Si-Tahar M, Humbles AA, Courty Y.

Gene. 2016 Jul 15;586(1):176-83. doi: 10.1016/j.gene.2016.04.022. Epub 2016 Apr 11.

PMID:
27080955
25.

Phylogenomic exploration of the relationships between strains of Mycobacterium avium subspecies paratuberculosis.

Bryant JM, Thibault VC, Smith DG, McLuckie J, Heron I, Sevilla IA, Biet F, Harris SR, Maskell DJ, Bentley SD, Parkhill J, Stevenson K.

BMC Genomics. 2016 Jan 26;17:79. doi: 10.1186/s12864-015-2234-5.

26.

Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study.

Saadoun D, Thibault V, Si Ahmed SN, Alric L, Mallet M, Guillaud C, Izzedine H, Plaisier A, Fontaine H, Costopoulos M, Le Garff-Tavernier M, Hezode C, Pol S, Musset L, Poynard T, Cacoub P.

Ann Rheum Dis. 2016 Oct;75(10):1777-82. doi: 10.1136/annrheumdis-2015-208339. Epub 2015 Nov 13.

PMID:
26567178
27.

[Online Activities to Support Networking in Mental Health Practices in Quebec].

Michaud D, Briand C, Thibault V, Charbonneau K.

Sante Ment Que. 2015 Spring;40(1):227-49. French.

PMID:
26355489
28.

Hepatitis E infection in patients with severe alcoholic hepatitis: is there a place for systematic screening?

Rudler M, Thibault V, Mouri S, Akhavan S, Mallet M, Charlotte F, Poynard T, Thabut D.

Eur J Gastroenterol Hepatol. 2015 Dec;27(12):1367-71. doi: 10.1097/MEG.0000000000000459.

PMID:
26308710
29.

Prevalence of hepatitis B virus in primary central nervous system lymphoma.

Faivre G, Thibault V, Tanguy ML, Leblond V, Choquet S, Soussain C, Gonzalez-Aguilar A, Sierra del Rio M, Houillier C, Hoang-Xuan K, Idbaih A.

J Neurooncol. 2015 Oct;125(1):219-21. doi: 10.1007/s11060-015-1879-x. Epub 2015 Aug 14. No abstract available.

PMID:
26272598
30.

Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients.

Le Guillou-Guillemette H, Ducancelle A, Bertrais S, Lemaire C, Pivert A, Veillon P, Bouthry E, Alain S, Thibault V, Abravanel F, Rosenberg AR, Henquell C, André-Garnier E, Petsaris O, Vallet S, Bour JB, Baazia Y, Trimoulet P, André P, Gaudy-Graffin C, Bettinger D, Larrat S, Signori-Schmuck A, Saoudin H, Pozzetto B, Lagathu G, Minjolle-Cha S, Stoll-Keller F, Pawlotsky JM, Izopet J, Payan C, Lunel-Fabiani F.

J Clin Virol. 2015 Aug;69:203-9. doi: 10.1016/j.jcv.2015.06.096. Epub 2015 Jun 24.

31.

The increase in serum 25-hydroxyvitamin D following weight loss does not contribute to the improvement in insulin sensitivity, insulin secretion and β-cell function.

Thibault V, Morisset AS, Brown C, Carpentier AC, Baillargeon JP, Langlois MF, Gagnon C.

Br J Nutr. 2015 Jul;114(2):161-8.

PMID:
26132208
32.

Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study.

Terrier B, Lapidus N, Pol S, Serfaty L, Ratziu V, Asselah T, Thibault V, Souberbielle JC, Carrat F, Cacoub P.

World J Gastroenterol. 2015 May 14;21(18):5647-53. doi: 10.3748/wjg.v21.i18.5647.

33.

Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin.

Larrat S, Vallet S, David-Tchouda S, Caporossi A, Margier J, Ramière C, Scholtes C, Haïm-Boukobza S, Roque-Afonso AM, Besse B, André-Garnier E, Mohamed S, Halfon P, Pivert A, LeGuillou-Guillemette H, Abravanel F, Guivarch M, Mackiewicz V, Lada O, Mourez T, Plantier JC, Baazia Y, Alain S, Hantz S, Thibault V, Gaudy-Graffin C, Bouvet D, Mirand A, Henquell C, Gozlan J, Lagathu G, Pronier C, Velay A, Schvoerer E, Trimoulet P, Fleury H, Bouvier-Alias M, Brochot E, Duverlie G, Maylin S, Gouriou S, Pawlotsky JM, Morand P.

J Clin Microbiol. 2015 Jul;53(7):2195-202. doi: 10.1128/JCM.03633-14. Epub 2015 Apr 29.

34.

Definition of an HBsAg to DNA international unit conversion factor by enrichment of circulating hepatitis B virus forms.

Désiré N, Ngo Y, Franetich JF, Dembele L, Mazier D, Vaillant JC, Poynard T, Thibault V.

J Viral Hepat. 2015 Sep;22(9):718-26. doi: 10.1111/jvh.12387. Epub 2015 Jan 29.

PMID:
25644062
35.

Coexistence of circulating HBsAg and anti-HBs antibodies in chronic hepatitis B carriers is not a simple analytical artifact and does not influence HBsAg quantification.

Pancher M, Désiré N, Ngo Y, Akhavan S, Pallier C, Poynard T, Thibault V.

J Clin Virol. 2015 Jan;62:32-7. doi: 10.1016/j.jcv.2014.11.015. Epub 2014 Nov 18.

36.

PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.

Saadoun D, Resche Rigon M, Pol S, Thibault V, Blanc F, Pialoux G, Karras A, Bazin-Kara D, Cazorla C, Vittecoq D, Musset L, Peltier J, Decaux O, Ziza JM, Lambotte O, Cacoub P.

J Hepatol. 2015 Jan;62(1):24-30. doi: 10.1016/j.jhep.2014.08.015. Epub 2014 Aug 15.

PMID:
25135864
37.

Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®).

Poynard T, Vergniol J, Ngo Y, Foucher J, Thibault V, Munteanu M, Merrouche W, Lebray P, Rudler M, Deckmyn O, Perazzo H, Thabut D, Ratziu V, de Ledinghen V; FibroFrance Study Group and the Bordeaux HBV Study Group.

J Hepatol. 2014 Nov;61(5):994-1003. doi: 10.1016/j.jhep.2014.06.027. Epub 2014 Jul 10.

PMID:
25016224
38.

Could droplet digital PCR be used instead of real-time PCR for quantitative detection of the hepatitis B virus genome in plasma?

Boizeau L, Laperche S, Désiré N, Jourdain C, Thibault V, Servant-Delmas A.

J Clin Microbiol. 2014 Sep;52(9):3497-8. doi: 10.1128/JCM.01306-14. Epub 2014 Jul 2. No abstract available.

39.

Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).

Poynard T, Vergniol J, Ngo Y, Foucher J, Munteanu M, Merrouche W, Colombo M, Thibault V, Schiff E, Brass CA, Albrecht JK, Rudler M, Deckmyn O, Lebray P, Thabut D, Ratziu V, de Ledinghen V; FibroFrance Study Group; Epic3 Study Group; Bordeaux HCV Study Group.

J Hepatol. 2014 Apr;60(4):706-14. doi: 10.1016/j.jhep.2013.11.016. Epub 2013 Nov 26.

PMID:
24291240
40.

Molecular epidemiology and clinical characteristics of hepatitis B identified through the French mandatory notification system.

Thibault V, Laperche S, Thiers V, Sayon S, Letort MJ, Delarocque-Astagneau E, Antona D.

PLoS One. 2013 Sep 25;8(9):e75267. doi: 10.1371/journal.pone.0075267. eCollection 2013.

41.

Role of genotype G hepatitis B virus mixed infection on the progression of hepatic fibrosis in HIV positive patients over 5 years of follow-up.

Calin R, Guiguet M, Desire N, Imbert-Bismut F, Munteanu M, Poynard T, Valantin MA, Stitou H, Katlama C, Thibault V.

J Clin Virol. 2013 Oct;58(2):408-14. doi: 10.1016/j.jcv.2013.07.018. Epub 2013 Aug 6.

PMID:
23958588
42.

Anti-hepatitis C virus antibody detection in oral fluid: influence of human immunodeficiency virus co-infection.

Visseaux B, Larrouy L, Calin R, Katlama C, Poynard T, Ratziu V, Thibault V.

J Clin Virol. 2013 Oct;58(2):385-90. doi: 10.1016/j.jcv.2013.07.015. Epub 2013 Aug 13.

PMID:
23953940
43.

Efficacy and tolerance of telaprevir in HIV-hepatitis C virus genotype 1-coinfected patients failing previous antihepatitis C virus therapy: 24-week results.

Lacombe K, Valin N, Stitou H, Gozlan J, Thibault V, Boyd A, Poirier JM, Meynard JL, Valantin MA, Bottero J, Girard PM.

AIDS. 2013 May 15;27(8):1356-9. doi: 10.1097/QAD.0b013e32836138d0.

PMID:
23925383
44.

Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C.

Poynard T, Moussalli J, Munteanu M, Thabut D, Lebray P, Rudler M, Ngo Y, Thibault V, Mkada H, Charlotte F, Bismut FI, Deckmyn O, Benhamou Y, Valantin MA, Ratziu V, Katlama C; FibroFrance-GHPS group.

J Hepatol. 2013 Oct;59(4):675-83. doi: 10.1016/j.jhep.2013.05.015. Epub 2013 May 24.

PMID:
23712051
45.

Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2.0.

Larrat S, Poveda JD, Coudret C, Fusillier K, Magnat N, Signori-Schmuck A, Thibault V, Morand P.

J Clin Microbiol. 2013 Sep;51(9):2815-21. doi: 10.1128/JCM.00586-13. Epub 2013 Apr 24.

46.

Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24.

Saadoun D, Resche Rigon M, Thibault V, Longuet M, Pol S, Blanc F, Pialoux G, Karras A, Bazin-Karra D, Cazorla C, Vittecoq D, Musset L, Decaux O, Ziza JM, Lambotte O, Cacoub P.

Ann Rheum Dis. 2014 May;73(5):831-7. doi: 10.1136/annrheumdis-2012-202770. Epub 2013 Apr 20.

47.

Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study.

Thibault V, Gaudy-Graffin C, Colson P, Gozlan J, Schnepf N, Trimoulet P, Pallier C, Saune K, Branger M, Coste M, Thoraval FR; ANRS Multivir-HBV group.

Virol J. 2013 Mar 15;10:87. doi: 10.1186/1743-422X-10-87.

48.

Kinetic profiles and management of hepatitis B virus reactivation in patients with immune-mediated inflammatory diseases.

Droz N, Gilardin L, Cacoub P, Berenbaum F, Wendling D, Godeau B, Piette AM, Dernis E, Ebbo M, Fautrel B, Le Guenno G, Mekinian A, Bernard-Chabert B, Costedoat-Chalumeau N, Descloux E, Michot JM, Radenne S, Rigolet A, Rivière S, Yvin JL, Thibault V, Thabut D, Pol S, Guillevin L, Mouthon L, Terrier B.

Arthritis Care Res (Hoboken). 2013 Sep;65(9):1504-14. doi: 10.1002/acr.21990. Review.

49.

Multicenter quality control of hepatitis C virus protease inhibitor resistance genotyping.

Vallet S, Larrat S, Laperche S, Le Guillou-Guillemette H, Legrand-Abravanel F, Bouchardeau F, Pivert A, Henquell C, Mirand A, André-Garnier E, Giordanengo V, Lagathu G, Thibault V, Scholtes C, Schvoerer E, Gaudy-Graffin C, Maylin S, Trimoulet P, Brochot E, Hantz S, Gozlan J, Roque-Afonso AM, Soussan P, Plantier JC, Charpentier C, Chevaliez S, Colson P, Mackiewicz V, Aguilera L, Rosec S, Gouriou S, Magnat N, Lunel-Fabiani F, Izopet J, Morand P, Payan C, Pawlotsky JM.

J Clin Microbiol. 2013 May;51(5):1428-33. doi: 10.1128/JCM.03032-12. Epub 2013 Feb 20.

50.

Adjustment of antiretroviral regimen may lead to HBV reactivation even in patients with past HBV infection serological profile.

Seang S, Thibault V, Valantin MA, Katlama C.

J Infect Chemother. 2013 Oct;19(5):987-9. doi: 10.1007/s10156-013-0560-6. Epub 2013 Feb 5.

PMID:
23380971

Supplemental Content

Loading ...
Support Center